Against HSCT in Ph-positive ALL
18 Oct 2018
Against HSCT in Ph-positive ALL
Management of MLL-rearranged ALL
Update on targeted therapies for Philadelphia-like ALL
CAR-T cells: challenges and opportunities
Editor’s Choice for September 2018
Editor's Choice for August 2018
New important compounds for targeted and immunotherapies for lung cancer
Updates from a range of lung cancer studies
Rare mutations in non small cell lung cancer
Several important studies for lung cancer
Key advances in ALL and AML
Extended genetic testing and GYN cancer risk